Analysts are recommending several stocks with projected returns ranging from 11% to 36%. Key picks include United Spirits, Vedanta Aluminiu...

The Malayalam comedy-drama Aashaan, directed by Johnpaul George and starring Indrans in the lead role, is set to make its OTT debut soon. T...

Fund Manager Christy Mathai sees easing war-driven inflation fears, expecting a shorter earnings hit. He's selectively adding to his portfo...

Stock Reports Plus, powered by Refinitiv, undertakes detailed company analysis for 4,000+ listed stocks. In addition to detailed company an...

New Zealand is updating its skilled migrant and work-to-residence visa programs. New rules begin August 24, 2026. Wage thresholds are simpl...

Stock Reports Plus, powered by Refinitiv, undertakes detailed company analysis for 4,000+ listed stocks. In addition to detailed company an...

Reliance Industries' 49th AGM on June 19 is expected to draw investor attention for updates on the much-awaited Jio IPO, Reliance Retail's ...

Indian pharma is shifting from generics to innovation. This transformation, extending to 2035, is creating significant new opportunities. C...

Aman Chowhan of Abakkus Asset Manager highlights crude oil as the dominant macro risk, potentially impacting corporate earnings by 100-200 ...

Reliance Industries has added over Rs 1 lakh crore in market value in just three trading sessions ahead of its closely watched AGM. Despite...

Is your iPhone overheating and losing battery quickly?: Summer heat is causing iPhones to overheat. Users report dim screens and charging p...

The Sun transit in Gemini on June 15, 2026 brings a noticeable shift toward communication, networking, learning, adaptability, and new oppo...

Indian pharma stocks are outperforming the market, offering strong returns to investors. This resilience is driven by robust domestic deman...

Surya Grahan kab hai: An annular solar eclipse is scheduled for August 12, 2026. This celestial event will be visible in parts of Europe an...

Helios Mutual Fund is shifting investments from large companies to mid and small companies. This move follows earnings growth trends where ...

A promoter entity of Ajanta Pharma sold shares worth over Rs 1,024 crore through a block deal, with Kotak Mahindra Mutual Fund and Aditya B...

State Bank of India is set to commit up to $1 billion to fund Sun Pharmaceutical Industries Ltd.'s $12 billion acquisition of Organon & Co....